New Delhi, June 11 (IANS) India is rapidly emerging as a global pharmaceutical powerhouse and is well-positioned to lead the next wave of biopharmaceutical innovation, Union Minister of State for Health & Family Welfare and Chemicals & Fertilisers Anupriya Patel said on Thursday. While addressing ASSOCHAM’s Pharma Summit & Awards 2026, she highlighted the government’s efforts to strengthen domestic manufacturing, promote innovation, and build a resilient healthcare ecosystem capable …
Latest Department of Pharmaceuticals News & Updates
New Delhi, April 14 (IANS) While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ecosystem collaboration, and a shift towards innovation-led development to position the country as a global leader in advanced therapeutics, experts said on Tuesday.The two-day ‘India Pharma 2026’, organised by the Department of Pharmaceuticals, in association with FICCI and IPA, New Delhi, successfully concluded here. The event witnessed part…
New Delhi, April 14 (IANS) AI will play a pivotal role in accelerating drug discovery, enabling precision medicine and shaping a smarter, innovation-led healthcare ecosystem, according to experts.Pharma leaders emphasised reimagining processes rather than merely digitising existing systems. They highlighted the growing importance of strong data and technology foundations to enable scalable AI adoption and stressed the immediate benefits of automation in improving clinical efficiency.The first da…
New Delhi, April 13 (IANS) India is poised to lead the global pharmaceutical landscape due to its focus on biologics, biosimilars and specialty medicines, Health Minister JP Nadda said on Monday.The minister highlighted that the government recently launched Biopharma Shakti Initiative with an outlay of Rs 10,000 crore, to advance capabilities in biopharmaceutical innovation, foster innovation and strengthen research capabilities. Union Minister of State for Health and Family Welfare, Anupriya Pa…
New Delhi, April 11 (IANS) Aligned with India’s vision of emerging as a global pharma innovation hub, the ‘India Pharma 2026’ aims to accelerate the sector’s transition from a volume-driven model to a value- and innovation-led global powerhouse, according to an official statement on Saturday.The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, is set to organise the 9th edition of India Pharma 2026, in association with FICCI and the Indian Pharmaceutical Alliance (IP…
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and research-led expansion, the government said on Monday.The Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers, in association with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceuti…
Bhopal, Feb 15 (IANS) The Jan Aushadhi Kendra, opened in Madhya Pradesh’s Rajgarh district, is the new centre of activity as patients and their relatives are thronging the medical store to buy highly subsidised medicines, which elsewhere burn a hole in their pockets. Here, people are getting access to high-quality generic medicines at prices almost 50 to 90 per cent lower than their private counterparts. Many patients said that this has brought them mental as well as financial relief and thank…
New Delhi, Jan 5 (IANS) India’s pharmaceutical exports reached $30.47 billion in FY 2024–25, registering a 9.4 per cent year-on-year growth, and are on track to surpass last year’s performance in the current financial year, the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) informed Commerce Secretary Rajesh Agrawal on Monday.PHARMEXCIL also highlighted India’s position as the third-largest pharmaceutical producer globally by volume and a trusted supplier of affordable, q…
New Delhi, Jan 4 (IANS) The Centre has invited proposals under two marginal investment sub-schemes to reduce India’s heavy dependence on imported medical devices and support clinical studies in the medtech sector, more than a year after the schemes were first announced.India currently imports nearly 70 per cent of its medical device requirements. To address this gap, the Department of Pharmaceuticals launched a Rs 500 crore support package in November 2024 to strengthen domestic manufacturing …